Vitality Watch

⚠ Evidence note: Nutrition evidence is dominated by observational data with heavy confounding; trial endpoints are mostly surrogates, not lifespan.

Mentioned 1× · first seen 07-oct-2026 · last seen 07-oct-2026

Medium-Chain Triglycerides (MCT)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-29 — Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.: C. elegans mechanistic study: α-synuclein lipid binding and condensate formation progressively deplete triglycerides and disrupt lipid droplets and mitochondria with age; dietary MCT supplementation (or blocking long-chain unsaturated fatty acid synthesis) rescues motility and toxicity phenotypes, with a supporting observation of lower plasma TAGs in Parkinson’s cohorts. [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Condensate-driven triglyceride reduction links α-synuclein to mitochondrial dysfunction.
29-sep-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18